PTSM: Pharmaceutical Technology Sourcing and Management-06-06-2012

The key activity of the pharmaceutical majors influencing drug development and manufacturing thus far in 2012.

Needle-free jet injection systems, gold-coated nanoparticles, and elastic capsules with nanosized flakes advance targeted drug delivery.

Venture-capital funding is up in 2012, but public financing remains sluggish in the biopharmaceutical industry.

Advances in palladium-catalyzed hydrogenation, visible-light photocatalysis, and chemocatalyisis for heterocycles are some recent developments.

Service providers must focus on delivering a superior customer experience.

The pharmaceutical industry weighs in on WHO global health initiatives, including R&D for diseases of the developing world, a global vaccine action plan, neglected tropical diseases, and counterfeit medicines.

A roundup of developments in corporate social responsibility and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.